Articles tagged with Sepsis
Scientists at Ohio State University have created a treatment for late-stage sepsis using nanotechnology to transform donated immune cells into a powerful antibacterial drug. The therapy demonstrated significant improvements in survival rates and bacteria clearance in mouse models of sepsis.
Researchers found that energy-producing mitochondria in muscles were abnormal and showed signs of oxidative damage, contributing to chronic muscle weakness. The study suggests the need for antioxidant therapies or other treatments to restore mitochondrial health.
A national approach for pediatric sepsis surveillance has been developed, utilizing electronic health records to facilitate widespread tracking of rates and outcomes. The proposed approach includes a preliminary case definition adapted to address specific differences among infants and children.
A digital alert system has been introduced to monitor patients with sepsis, leading to lower odds of death and shorter hospital stays. The system has also increased the chances of receiving timely antibiotics, resulting in improved outcomes for patients.
Biomedical researchers at Cincinnati Children's Hospital Medical Center have developed a new rapid blood assay called PERSEVERE to detect and stratify sepsis. The test accurately predicts patient risk of death from sepsis, enabling early medical interventions with greater precision.
Researchers have developed a new way to measure white blood cell function, providing more accurate prognostic information for patients with sepsis. The technology assesses activation state and function of white blood cells from small blood samples, allowing for earlier diagnosis and treatment.
Dr. Judith Hellman has been awarded the American Society of Anesthesiologists' Excellence in Research Award for her groundbreaking research on sepsis and inflammatory critical illness. Her discoveries have led to improved understanding of inflammation, immune function, and potential treatments for sepsis.
A new rapid testing method is being used to improve antibiotic treatment for sepsis patients, enabling medical teams to make quicker and more targeted therapy choices. The study found that providing rapid drug susceptibility information can lead to better patient outcomes and less unnecessary broad-spectrum antibiotic use.
Researchers identified specific microRNAs that predict pneumonia complications, enabling early detection and intervention. The study found correlations between microRNA profiles and sepsis and respiratory failure in pneumonia patients.
A randomized clinical trial found that high-dose intravenous vitamin C did not reduce organ failure, inflammation, or vascular injury in patients with sepsis and acute respiratory distress syndrome (ARDS). The study's limitations include underpowered detection of differences and insufficient dosage.
A new study published in JAMA found that treating septic patients with intravenous vitamin C infusions significantly reduced mortality and improved recovery times. The trial showed a 30% reduction in mortality at day 28 compared to the placebo group, and patients spent three fewer days in the ICU.
A new study finds that drawing blood cultures after starting antimicrobial treatment can result in a significant loss of available clinical information. The study suggests that drawing blood cultures prior to treatment may be more effective in identifying the bacteria causing the infection and selecting the right antibiotic.
A new study has found that initiating antibiotics immediately before obtaining blood cultures significantly affects their sensitivity and ability to diagnose bacterial and fungal infections. This change in guidelines may reduce mortality rates from sepsis, a life-threatening condition with a 20% mortality rate.
A recent study published in Annals of Internal Medicine found that early blood sampling for microorganisms is critical to treating sepsis. Emergency rooms must follow sepsis guidelines, which demand trained personnel and proper equipment, to prevent organ damage and death.
A $40,000 grant from The Emergency Medicine Foundation is supporting a study to increase awareness among parents about sepsis signs in children. Researchers hope this will lead to improved recognition strategies and faster diagnosis of sepsis.
Researchers found that sevoflurane improved survival rates and reduced bacterial presence in organs of mice with induced sepsis compared to isoflurane or no anesthetic. The study suggests a critical role for the type of general anesthesia used in treating sepsis.
Researchers found altered gut microbiota in sepsis patients, leading to more severe liver damage in mice. The study suggests that transplantation of healthy feces may help treat sepsis in intensive care units.
Researchers investigated metabolic changes across organs in a large animal model of sepsis, identifying common and organ-specific alterations that could inform new therapeutic approaches. The study, published in The American Journal of Pathology, has the potential to reduce mortality and morbidity associated with sepsis.
Researchers at University of California San Diego School of Medicine found that removing the enzyme PHLPP1 improves outcomes in a mouse model of sepsis. The study introduces the possibility of inhibiting PHLPP1 as a new treatment for sepsis.
Sepsis survivors are at higher risk for major health problems and death due to persistent inflammation, according to a study published in JAMA Network Open. The researchers found that nearly all patients with sepsis have increased inflammation during hospitalization, but this inflammation often persists long after discharge.
A national study found that combining early home health nursing with at least one outpatient physician visit after hospital discharge reduces the risk of 30-day hospital readmission for sepsis patients. The intervention facilitates coordinated care planning and early surveillance, resulting in improved outcomes.
Scientists at WashU Medicine have found a set of genes that help cells survive exposure to cytokines, which can trigger a deadly cytokine storm. Targeting these genes may lead to new treatments for sepsis, a life-threatening condition that claims 15% of patients despite prompt medical care.
A study led by University of Pittsburgh researchers found that implementing a state-mandated sepsis regulation in New York resulted in a significant drop in death rates from sepsis, with a 4.3% decrease compared to control states. The policy requires hospitals to quickly implement certain protocols when sepsis is suspected.
State-mandated protocols for sepsis care in New York have been associated with significant improvements in patient outcomes, including a reduced risk of death. The study analyzed hospital discharge data and found that these regulations led to better management of sepsis cases, resulting in improved survival rates.
A new study found that while the New York Sepsis Initiative improved overall sepsis care, hospitals treating mainly white patients saw greater increases in protocol compliance than those serving more black patients. This disparity raises concerns about the potential exacerbation of racial disparities in healthcare.
A multicentre study analyzed over 1.9 million pediatric emergency department visits and found no significant association between overcrowding and death within 14 days or hospital admission within 7 days. However, the study saw an increase in admissions among sicker children and return visits from less sick kids with increasing crowding.
A new study found that delayed antibiotic delivery for sepsis patients is associated with lower ER triage scores, particularly among those assigned mid-range scores. This delay can result in longer door-to-antibiotic times of up to 32 minutes, impacting patient survival.
Researchers used big data to identify four distinct subtypes of sepsis, each with unique clinical characteristics and treatment needs. These findings could lead to the development of precision medicine approaches for sepsis treatment, potentially improving patient outcomes.
Researchers have discovered a biochemical compound responsible for the rapid decline in blood pressure during sepsis. The compound, cis-WOOH, is formed by an enzyme and plays a signaling role in vasodilation, potentially leading to organ failure and death.
Scientists have discovered that bacterial proteins and endotoxin activate the inflammasome, leading to pyroptosis and the release of tissue factor, which initiates blood clotting. This understanding may lead to new treatments for sepsis by targeting inflammatory responses.
A KAIST research team visualized pulmonary microcirculation in vivo using a custom-built 3D intravital microscope imaging system. They found that neutrophils aggregate inside capillaries during sepsis-induced acute lung injury, leading to tissue hypoxia and damage.
A new computer-aided model developed in the UK can predict sepsis risk using routinely collected data. The cNEWS score can trigger screening within 30 minutes of admission and support clinical judgment.
The Society for Maternal-Fetal Medicine has released new guidelines for diagnosing and treating sepsis in pregnancy, emphasizing the importance of early recognition and management. The recommendations are designed to improve care and prevent organ damage caused by sepsis, with a focus on increasing maternal survival rates.
Researchers will compare DNA from sepsis patients who died and survived to isolate signals and identify future drug targets. The study, funded by Sepsis Research, aims to better understand how genes govern sepsis recovery.
A study published in JAMA Network Open found that sepsis was present in over 50% of terminal hospitalizations and accounted for 35% of all deaths. However, only one in twenty-five sepsis-associated deaths were considered moderately or highly likely preventable.
A pre-clinical trial of InnovoSep has demonstrated potential to stop sepsis-causing bacteria from triggering organ damage. The drug also showed effectiveness in preventing sepsis progression and treating advanced sepsis.
A recent grant will allow researcher Wendy Walker to study immune cell contributions to sepsis, a life-threatening disorder with a high mortality rate. Her goal is to manipulate these cells to improve clinical outcomes and potentially cure the disease.
Researchers found that delaying or withholding antibiotics for older adults with urinary tract infections increases the risk of bloodstream infections and death. Immediate antibiotic treatment is recommended for this vulnerable group due to their increased susceptibility to sepsis following UTI.
Researchers found that early antibiotic treatment for elderly patients with urinary tract infections (UTIs) reduces the risk of sepsis and death compared to delayed or no treatment. The study suggests that immediate antibiotics should be prescribed for elderly patients with UTIs, especially older men and those living in deprived areas.
Scientists at the University of British Columbia have discovered a new protein 'switch' that can stop the progression of sepsis, a life-threatening disease. This discovery could lead to new treatments for chronic and acute inflammatory diseases.
Sepsis-associated deaths occurred in over half of hospitalizations, with most deaths attributed to complex patients with severe coexisting conditions. Further innovations in prevention and care of underlying conditions may be necessary to reduce sepsis deaths
A study from the University of Virginia Health System suggests that an antidepressant drug could stop deadly sepsis by regulating inflammation. The researchers tested the drug in a mouse model and found it to be effective, paving the way for potential human trials.
A Western diet characterized by low fiber and high fat and sugar content can lead to increased chronic inflammation, higher mortality rates, and more severe sepsis severity in mice. The study identifies molecular markers that could predict patients at high risk for severe sepsis or require aggressive treatment.
Researchers have successfully engineered a protein that balances an overreaction of the immune system, making it a promising candidate for sepsis therapy. By understanding how interleukins mediate communication between immune cells, scientists can now modulate their reaction in a targeted manner.
A synthetic compound derived from flaxseed has been shown to reverse cardiovascular dysfunction and improve heart function in mice with sepsis. Treatment with the antioxidant LGM2605 significantly reduced oxidative stress and restored energy production in heart cells.
Basophils, a rare type of white blood cell, have been found to play a crucial role in preventing sepsis. By releasing protein tumor necrosis factor (TNF), basophils trigger an immune response that helps protect against infection and prevents the progression to sepsis.
A large clinical study in Australia and New Zealand aims to better understand sepsis treatment practices and evaluate the effectiveness of a reduced fluid approach. The study, funded by the Emergency Medicine Foundation, will investigate how intravenous fluids are used to treat sepsis patients.
In a breakthrough study, researchers successfully delivered a microRNA called miR-126 via a nanocarrier to improve survival rates in a preclinical model of sepsis. The treatment resulted in over 67% of mice being alive at seven days compared to just 25% of untreated mice.
A study reveals that current screening tools can miss severe infections in pregnant women, highlighting the need for better identification and timely interventions. Simple measures such as frequent vital sign reassessment and prompt antibiotic administration within an hour of diagnosis can significantly reduce maternal deaths.
Researchers developed an AI Clinician system that predicts and recommends optimal treatment strategies for patients with sepsis, showing a higher chance of survival compared to human doctors. The system analyzed 100,000 hospital records and made more reliable treatment decisions than humans.
Researchers have developed a new method for administering the antibiotic ceftriaxone through rectal delivery, which could save thousands of newborn lives annually. The approach builds upon earlier work and has been shown to be effective in treating critically ill patients with sepsis.
Researchers at Kazan Federal University investigated the virulence factors of Klebsiella pneumoniae in neonates with sepsis and urinary tract infections. They found that rmpA gene-containing strains were associated with more severe diseases, revealing a higher prevalence of virulent K. pneumoniae strains than previously thought.
A new report in the American Journal of Pathology demonstrates a link between prenatal inflammation and postnatal immune status and organ function in preterm pigs. Prenatal exposure to bacterial endotoxin induced acute fetal lung and gut immune responses, followed by systemic inflammation after birth.
A new study found increasing infection rates for urinary tract infections, sepsis, and skin infections among people with diabetes in the USA. Rates of infection-related hospitalisations increased by 52% between 2010 and 2015 compared to the general population.
The article discusses clinical early warning scores as new clinical tools to predict future clinical deterioration, particularly related to sepsis. It provides a critical review of the state-of-the-art in early warning algorithms and suggests further research initiatives.
A commentary suggests using smart technology and artificial intelligence to improve the detection of sepsis in children in Canada. The authors propose automating data combinations of sepsis symptoms and other relevant information to create more accurate and low-cost trigger tools.
A large Taiwanese study found that patients with sepsis are at increased risk of cardiovascular events, including stroke and heart attack, within the first 4 weeks after hospital discharge. Younger patients with sepsis aged 20 to 45 years were particularly at higher risk.
A team of researchers from Case Western Reserve University discovered a way to stop immune cell death associated with multiple diseases, including sepsis, IBD, and arthritis. They identified a chemical, necrosulfonamide, that potently inhibits inflammatory cell death by preventing pyroptosis, a type of cell suicide.
A £2 million project, ARCS, aims to tackle sepsis in Africa by creating sustainable partnerships between research, clinical, and government organizations. The initiative focuses on delivering high-quality training, establishing care quality indicators, and testing innovative interventions.
Researchers at UCalgary discovered the key target of a toxin that worsens sepsis caused by Staphylococcus aureus. The findings suggest an antibody targeting this toxin could prevent platelet aggregation and organ failure, offering new hope for patients in intensive care.